Mode
Text Size
Log in / Sign up
N/A N=1,339 Screening

Implementation of Adverse Childhood Experiences (ACEs) Policy

Adverse Childhood Experiences

Enrolled (actual)
1,339
Serious AEs
Results posted
May 2025
Primary outcome: Primary: ACEs Screenings Reach — 0; 468; 73 Participants

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Implementation Strategy of ACEs Screenings (Other); Usual Care (Other)
Age
Pediatric · 0+ yrs
Sex
All
Sponsor
University of Colorado, Denver
Primary completion
Apr 2024

Outcome Measures

OutcomeResultp-value
PRIMARY
ACEs Screenings Reach
0; 468; 73
PRIMARY
Mental Health Service Referral
6; 302; 4
SECONDARY
Changes in Baby Pediatric Symptoms (BPSS) / Preschool PSC (PPSC)
111; 6 0.03 sig
SECONDARY
Acceptability of the Strategy
2.98
SECONDARY
Feasibility of the Strategy
2.97

Summary

Adverse Childhood Experiences (ACEs) are pervasive among children with 45% experiencing at least one ACE and 10% experiencing three or more, placing them at high risk for toxic stress and symptomatology. Yet, ACEs often go undetected in primary care settings during well-child visits due to unclear policies and tested implementation strategies. This pilot study will use mapping methodology, guided by the Exploration, Preparation, Implementation and Sustainment (EPIS) framework, to refine a multi-faceted strategy supporting the implementation of the state of California's 2020 policy promoting universal ACE screening in community clinics, and a stepped-wedge trial to test the impact of the strategy on implementation and child-level outcomes.

Eligibility Criteria

Inclusion Criteria

  • Children ages 0-5 scheduled for wellness visit for upcoming week
  • Caregiver of child is 18 years or older with legal custody or authority to arrange care for child
  • Caregiver provides informed consent; signs consent form and HIPAA release form as well as coronavirus disease (COVID-19) information sheet
  • Caregiver agrees to complete the Pediatric Symptoms Checklist or PSC
  • Caregiver provides permission for socio-demographic information about their child to be pulled from EMR records, de-identified, and shared with PI

Exclusion Criteria

  • Children ages 0-5 scheduled for wellness visit for upcoming week
  • Caregiver declines to provide signed informed consent, HIPAA release, or permission for socio-demographic data to be pulled from the Electronic Medical Records (EMR), de-identified and shared with PI; or declines to respond to 17 questions for the PSC
  • Children ages 6-18 scheduled for wellness visits
  • Children ages 0-5 scheduled for wellness visits outside the study data collection windows or at clinics not providing pediatric care
  • Caregiver does not have legal guardianship or written authority to arrange care for the child
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04916587). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search